Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101930405 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ANKRD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
B3GALT5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMO5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL9A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDRT15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996286 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC16B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSFL1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CSNK1G1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOXL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLIM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MICALCL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POU2F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on